COLL — Collegium Pharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapSuper Stock

Annual balance sheet for Collegium Pharmaceutical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	186	174	311	163	387
Net Total Accounts Receivable
Net Total Receivables	106	183	180	229	211
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	316	420	538	482	691
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	27.1	26.4	22	20.2	16.2
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	692	1,174	1,143	1,664	1,657
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	280	434	458	510	440
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	489	979	948	1,435	1,355
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	203	195	195	229	302
Total Liabilities & Shareholders' Equity	692	1,174	1,143	1,664	1,657
Total Common Shares Outstanding